Treating substance use disorders.R, WandWand, R. (1998, July=August). Treating substance use disorders. OT Practice, 3, 35-42.
Depending on the severity of substance use disorder, and the given substance, early treatment of acute withdrawal may include medical detoxification. Of note, acute withdrawal from heavy alcohol use should be done under medical supervision to prevent a potentially deadly withdrawal syndrome known as de...
Posttraumatic stress disorder (PTSD) and substance use disorder (SUD) have high comorbidity. Although prior research indicated that PTSD can effectively be treated with Prolonged Exposure (PE) in these patients, reported effects are small and treatment dropout rates high. Eye Movement Desensitization an...
Since the United States COVID-19 pandemic emergency began, telemedicine use has accelerated [1]. Prior to the pandemic, mental health and/or substance use disorder (MH/SUD) care delivered by telemedicine had been increasing but infrequently used—in fewer than 1% of visits [2, 3]. In ...
Pediatric ADHD commonly co-occurs with multiple psychiatric disorders including mood, anxiety and disruptive behavioral disorders [9,10]. Likewise, adult ADHD is also associated with diagnoses of comorbid mood, anxiety and substance-use disorder [11–17]. Comorbidity rates in adult ADHD do not diffe...
Pediatric ADHD commonly co-occurs with multiple psychiatric disorders including mood, anxiety and disruptive behavioral disorders [9,10]. Likewise, adult ADHD is also associated with diagnoses of comorbid mood, anxiety and substance-use disorder [11–17]. Comorbidity rates in adult ADHD do not diffe...
[1]. Prior to the pandemic, mentalhealth and/or substance use disorder (MH/SUD) care delivered bytelemedicine had been increasing but infrequently used—in fewerthan 1% of visits [2, 3]. In contrast, in early October 2020, 41% ofMH/SUD visits were conducted via telemedicine [4]. The ...
The term “psychological disorder,” as used herein, includes, but is not limited to, disorders of mood and affect, memory dysfunction, motor and tic disorders, substance abuse disorders, psychotic disorders, and anxiety disorders. Psychological disorders may be recognized as described in the Diagnos...
The invention described herein is intended for use in any of the above vertebrate species.The term “patient,” refers to a living organism suffering from or prone to a condition that can be prevented or treated by administration of a NASP of the invention, and includes both humans and ...
USE OF SUBSTANCE P ANTAGONISTS FOR TREATING SOCIAL PHOBIAThe invention relates to the use of a compound of formula (I) or of a pharmaceutically utilizable salt thereof, in which R1 is an unsubstituted or substituted aralkyl, aryloxyalkyl, heteroaralkyl, aroyl, heteroaroyl, cycloalkylcarbonyl, ...